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Abstract
MicroRNA (miRNA) biogenesis and miRNA-guided RNA interference (RNAi) are essential for 
gene expression in eukaryotes. Here we report that translation initiation factor eIF1A directly 
interacts with Ago2 and promotes Ago2 activities in RNAi and miR-451 biogenesis. Biochemical 
and NMR analyses demonstrate that eIF1A binds to the MID-domain of Ago2 and this interaction 
does not impair translation initiation. Alanine mutation of the Ago2-facing Lys56 in eIF1A 
impairs RNAi activities in human cells and zebrafish. The eIF1A-Ago2 assembly facilitates Dicer-
independent biogenesis of miR-451, which mediates erythrocyte maturation. Human eIF1A 
(heIF1A), but not heIF1A(K56A), rescues the erythrocyte maturation delay in eif1axb knockdown 
zebrafish. Consistently, miR-451 partly compensates erythrocyte maturation defects in zebrafish 
with eif1axb knockdown and eIF1A(K56A) expression, supporting a role of eIF1A in miRNA-451 
biogenesis in this model. Our results suggest that eIF1A is a novel component of the Ago2-
centered RNA induced silencing complexes (RISCs) and augments Ago2-dependent RNAi and 
miRNA biogenesis.
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microRNAs (miRNAs) are ~22 nucleotide (nt) endogenous noncoding RNAs involved in 
gene expression regulation. Their genes are usually transcribed by RNA polymerase II or 
III1,2. The resulting primary miRNAs (priRNAs) contain characteristic hairpins, which are 
excised in the nucleus by Drosha/DGCR8 to yield the pre-miRNAs3,4. Subsequently, the 
Exportin-5/Ran-GTP complex translocates the pre-miRNAs to the cytoplasm5,6, where they 
are engaged by DICER to form a RISC Loading Complex (RLC). RLC includes TRBP and 
Ago27–9, while ADAR1 facilitates pre-miRNA loading10. In the canonical miRNA 
biogenesis pathway, DICER removes the terminal loop region to yield the mature 
miRNA11–13. Recent studies revealed that miR-451 is produced by an alternative DICER-
independent pathway, where pre-miR-451 is loaded directly onto Ago2 and sliced on the 3′ 
hairpin arm, as guided by the 5′ end of the hairpin, yielding a 30nt cleaved species14–16. A 3′ 
resection activity by PARN trims ~ 7-nt to produce the 23-nt miR-45117. However, the 
mechanisms of DICER-independent miRNA biogenesis have remained elusive.
miRNAs are incorporated into effector ribonucleoprotein complexes called RNA induced 
silencing complexes (RISCs) to exert RNA interference. RISCs can suppress translation 
without mRNA degradation, destabilize mRNAs by deadenylation or directly degrade 
mRNAs by Ago2 slicer activity12,18–20, and inhibit translation at the stage of initiation or 
elongation21,22. The core of RISCs is a member of the Ago protein family23. In mammals, 
this family consists of four members (Ago1–4). Although these four Ago proteins can 
suppress translation of their target mRNAs, only Ago2 (also known as eIF2C2) is 
endonucleolytically active19,20. Ago2 is composed of four globular domains (N, PAZ, MID 
and PIWI) and two structured linker domains (L1 and L2)24. MID and PAZ domains harbor 
the 5′-phosphate and 3′-hydroxyl termini of miRNA, respectively25,26, while the PIWI 
domain is responsible for the cleavage—slicer—activity27,28. Crystal structures of human 
Ago2 revealed that the 5′-end of miRNA is tethered to Argonaute through interactions with 
a binding pocket that is mostly formed by the MID domain29,30.
Eukaryotic translation initiation factor eIF1A is composed of a globular domain (GD) and 
two unstructured tails (N- and C-terminal tail), which are absent in prokaryotic initiation 
factor-1 (IF1). The eIF1A globular domain consists of an IF homologous oligonucleotide/
oligosaccharide binding (OB) fold, and an additional subdomain C-terminal to the OB fold 
that contains two alpha helices and two extended strands, which pack to the helix on 
opposite sites. The globular domain contains a large RNA binding face31, which is directed 
towards the ribosome 32,33
Here we find that the GD of eIF1A, which is conserved from IF1 to eIF1A, directly binds to 
Ago2, and that the MID-domain of Ago2 interacts with eIF1A but does not affect eIF1A’s 
function in translation initiation. eIF1A forms a complex with Ago2 and promotes Ago2 
cleavage activity in RNAi, and enhances Ago2 activity in miR-451 production in human 
cells and the developing zebrafish. The results support the notion that eIF1A is a component 
of the Ago2-centered RISCs.
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Results
eIF1A interacts with Ago2
To identify new components of the protein networks that participate in DICER-independent 
miRNA biogenesis and Ago2-mediated RNAi, we generated a human embryonic kidney 293 
(HEK293) cell line that stably expresses Flag-HA (haemagglutinin)-Ago2 for 
immunoprecipitation analyses. Eukaryotic translation initiation factor eIF1A is a previously 
unrecognized Ago2-interaction protein that is immunoprecipitated by Ago2 in cell lysates 
and colocalizes with Ago2 in mammalian cells (Fig. 1a–b). To test the specificity of the 
eIF1A–Ago interaction, we tested for possible interactions with other members of the Ago 
family using HEK293 cells stably expressing Ago 1–434. Transiently overexpressed eIF1A 
showed interaction with Ago2, but not Ago1, Ago3 or Ago4 (Fig. 1c).
eIF1A binds to Ago2 in an RNA-independent manner
To identify which of the individual domain(s) of Ago2 interacts with eIF1A, we examined 
the interaction of recombinant—RNase A and Benzonase-treated—L1, PAZ, MID and PIWI 
domains of Ago2 with GST-tagged-eIF1A in pull down assays. RNA free eIF1A specifically 
interacted with the RNA free MID-domain (Fig. 2a and Supplementary Fig. 1a). To further 
characterize the interaction between human eIF1A fragments and Ago2, we screened 
recombinant GST-tagged eIF1A and eIF1A mutants (N-tail deletion, C-tail deletion, and 
globular domain, Supplementary Fig. 1b–c) for interaction with Ago2. GST-tagged full 
length, N-tail deletion (ND), C-tail deletion (CD) and globular domain (GD) of eIF1A 
interacted with Ago2 but not the GST-tag alone, indicating that the eIF1A-GD is required 
and sufficient for the interaction with Ago2 (Fig. 2b). We further investigated the interaction 
between RNase A and Benzonase-treated eIF1A and the MID-domain by Nuclear Magnetic 
Resonance (NMR) spectroscopy. Unlabeled, Sumo-tagged MID domain titrated into a 15N-
labeled sample of eIF1A at molar ratio of 1:1 (eIF1A:SMT3-MID) (Fig. 2c) resulted in 
broadening of eIF1A resonances characteristic of the complex being in an intermediate 
exchange regime. The resonances of the eIF1A-GD experience more broadening when 
compared to the unstructured tails. For instance, resonances of Val55, Lys56 and Lys67 
residues of 15N-eIF1A-GD show broadening upon MID domain titration (Fig. 2c). These 
results suggest that the interaction of eIF1A and Ago2 primarily involves the GD of eIF1A. 
Furthermore, when unlabeled RNA free eIF1A was titrated to the RNA free 15N-MID-
domain at molar ratio of 1:1, we observed broadening of the MID resonances indicative of 
direct binding between the two proteins (Fig. 2d). We verified that eIF1A does not bind to 
the SMT3-tag (strong signals in Fig. 2d). These NMR data demonstrate that eIF1A directly 
interacts with Ago2 in an RNA independent manner.
Ago2 interaction does not impair eIF1A translation functions
Based on the observed spectral changes (Fig. 2c) we generated three eIF1A mutants: V55A, 
K56A and K67A. To test whether the mutants are folded we recorded a TROSY HSQC 
spectrum of eIF1AK56A. The spectrum clearly shows that eIF1AK56A is properly folded 
(Supplementary Fig. 2). To examine the roles of Val55, Lys56 and Lys67 of eIF1A in full 
length eIF1A-Ago2 interaction, we generated HEK293 cell lines stably expressing single 
eIF1A mutants (V55A, K56A or K67A) involved in Ago2-eIF1A interaction. As determined 
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by immunoprecipitation, all three mutations reduced eIF1A-Ago2 interaction (Fig. 3a), 
suggesting that these amino acids in eIF1A are important for the interaction between Ago2 
and full-length eIF1A. In an in vitro dual luciferase translation assays, elevated eIF1AK56A 
increases cap-dependent and IRES-dependent translation, to a similar degree as wild type 
eIF1A (Fig. 3b), suggesting that the K56A mutation does not compromise the activity of 
eIF1A in translation initiation. In addition, eIF1AK56A does not repress polysome complex 
formation activities in polysome profiling analyses (Fig. 3c), indicating that the K56A 
mutation does not generally impair translation.. Taken together, the data suggests that eIF1A 
directly interacts with Ago2 in an RNA-binding-independent manner, the MID-domain of 
Ago2 binds to the GD of eIF1A, and that the interaction between eIF1A and Ago2 does not 
impair eIF1A functions in translation initiation.
eIF1A promotes Ago2-mediated miRNA-guided RNAi in vitro
To examine whether eIF1A plays a role in Ago2-mediated RNAi, we employed a human 
HMGA2 3′-UTR mutant which harbors a characterized native let-7 target site35 (Fig. 4a). 
This assay evaluates the dependence of eIF1A and its mutants on let-7a/Ago2 mediated 
cleavage of the target mRNA. In the RNAi in vitro assay reactions with added eIF1A or 
eIF1A mutants without Ago2, no cleavage product was observed, suggesting that the 
cleavage is Ago2 dependent (Fig. 4b). Interestingly, we found that high concentrations of 
eIF1A increased HMGA2 3′-UTR mutant cleavage while eIF1A mutants (V55A, K56A and 
K67A) significantly reduced the level of cleavage products (Fig. 4b–c), indicating that 
eIF1A augments Ago2-mediated RNAi activities in vitro. To investigate the effects of 
eIF1A in Ago2-mediated miRNA-guided RNAi activities in cells, we used green fluorescent 
protein (GFP) reporters containing let-7 targeted sequences36. Because transient knockdown 
of eIF1A in HEK293 cells led to significant decrease of cell viability (Supplementary Fig. 
3), we employed specific eIF1A-Ago2 interaction interference with eIF1AK56A. Increased 
eIF1A levels elevated let-7 RISC activity, while eIF1A (K56A) mutant compromised let-7 
RISC activity (Fig. 4d–e). Elevated eIF1A and Ago2 decrease cellular GFP mRNA levels as 
determined by qPCR (Fig. 4f). In contrast, eIF1AK56A caused increased cellular GFP 
mRNA levels (Fig. 4f). These results suggest that eIF1A forms a complex with Ago2 and 
promotes Ago2-mediated RNAi in human cells in vitro.
eIF1A promotes Ago2-mediated miRNA-guided RNAi in vivo
To further evaluate the roles of eIF1A on Ago2-mediated RNAi in an animal model, we 
employed zebrafish. Both zebrafish paralog eIF1AXa and eIF1AXb interact with Ago2 
(Supplementary Fig. 4a–b). eif1axb mRNA level is much higher (> 25-fold) than that of 
eif1axa in the developing zebrafish (Supplementary Fig. 4c–d) therefore we focused on 
eif1axb here. We employed a lower dosage of eif1axb Morpholino (MO, 62.5μM, 1nl), 
which does not significantly affect zebrafish phenotypes at 18 h.p.f and 48 h.p.f 
(Supplementary Fig. 4e–f). Previous studies reported that miR-126 targets c-Myb and 
suppresses c-Myb expression in zebrafish37. We next examined if eIF1A plays a role in 
Ago2-mediated miR-126-guided c-Myb suppression in zebrafish at 28 h.p.f. Zebrafish 
treated with eif1axb MO (62.5μM, 1nl) showed increased c-Myb in comparison to the 
control group (Fig. 4g). Zebrafish with treatment of eif1axb MO (62.5μM, 1nl) plus human 
eIF1A (heIF1A, 1μg/μl mRNA, 1nl) presented decreased c-Myb levels compared to the 
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group treated with only eif1axb MO (62.5μM, 1nl). In contrast, zebrafish treated with human 
eIF1AK56A (1μg/μl mRNA, 1nl) and eif1axb MO (62.5μM, 1nl) show increased c-Myb (Fig. 
4g). In addition, heIF1AK56A increased c-Myb mRNA accumulation in zebrafish (Fig. 4h), 
indicating that interfering with eIF1A-Ago2 interaction impairs the miR-126-mediated 
suppression of c-Myb expression in zebrafish, even though the level of miR-126 remain is 
not significantly decreased under these conditions (Fig. 4i). These results demonstrated that 
eIF1A-Ago2 complex promotes miR-126 RISC activities in vivo. Overall the above results 
demonstrate that eIF1A augments Ago2-mediated miRNA-guided RNAi both in vitro and in 
vivo.
eIF1A stimulates miR-451 biogenesis in vitro and in vivo
Ago2 is important for Dicer-independent generation of mature miR-451, a micro RNA that 
regulates erythropoiesis 14–16. We therefore investigated whether eIF1A is involved in 
Ago2-mediated DICER-independent miRNA biogenesis. In vitro analyses of eIF1A/Ago2-
dependent cleavage of pre-miR-451 showed that reactions with eIF1A or eIF1A mutants but 
without Ago2 displayed no pre-miR-451 cleavage (Fig. 5a). In the presence of Ago2, 
however, eIF1A enhances pre-miR-451 cleavage in a dose-dependent manner (Fig. 5a–b). In 
contrast, the point mutation of V55A, K56A or K67A impaired the activity of Ago2 in this 
assay (Fig. 5a–b). These results suggest that eIF1A forms a complex with Ago2 to facilitate 
pre-miR-451cleavage. In Northern blot assays, eIF1A mutants (V55A, K56A, or K67A) in 
stable HEK293 cells consistently decreased the production or accumulation of mature 
miR-451 in comparison to wild type eIF1A (Fig. 5c). Importantly, the level of miR-144—
which is processed from the same precursor transcript as miR-45114,15—remained 
unchanged (Fig. 5c). These results suggest that eIF1A promotes Ago2-dependent miR-451 
biogenesis in human cells in vitro. While the levels of miRNA-451 increased during 
development from 24 h.p.f. to 56 h.p.f in wild type zebrafish, eif1axb knockdown lead to 
decreased miR-451production (Fig. 5d). Human eIF1A (1μg/μl mRNAs, 1nl) could rescue 
miR-451 production in eif1axb knockdown zebrafish (Fig. 5d). In contrast, heIF1AK56A 
failed to rescue miR-451 production during zebrafish development (Fig. 5d), indicating that 
eIF1A-Ago2 interaction plays a role in miR-451 biogenesis in vivo. Importantly, eif1axb 
knockdown does not decrease miR-144 production, indicating that eIF1A does not affect 
Ago2-independent miRNA production (Fig. 5d). These results demonstrated that eIF1A 
forms a complex with Ago2 and augments Ago2-dependent miR-451 biogenesis in 
zebrafish.
eIF1A modulates miR-451 mediated erythrocyte maturation
Recent studies have reported that miR-451 plays an important role in erythrocyte maturation 
in zebrafish15,38,39. Consistent with a role for eIF1A in miR-451 biogenesis, injection of 
human eIF1A mRNAs (1μg/μl, 1nl, n = 35 embryos), but not mRNAs encoding human 
eIF1AK56A (1μg/μl, 1nl, n = 35), rescues the reduced hemoglobinized cells in zebrafish with 
eif1axb gene knockdown (Fig. 5e–f). Importantly, miR-451 (0.2μg/μl, 1nl, n = 31) partly 
compensated the decrease in hemoglobinized cells in zebrafish treated with eif1axb 
knockdown or heIF1AK56A (Fig. 5e–f). Furthermore, heIF1A (n = 120 erythrocytes), but not 
heIF1AK56A mutant (n = 145 erythrocytes), rescued erythrocyte maturation in zebrafish with 
eif1axb knockdown. Notably, miR-451 (0.2μg/μl, 1nl, n = 118 erythrocytes) rescued 
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erythrocyte maturation delay caused by heIF1AK56A expression (Fig. 5g–h). These results 
demonstrate that eIF1A modulates miR-451 production in zebrafish. Taken together, our 
data demonstrate that eIF1A forms a complex with Ago2 and promotes Ago2-mediated 
miRNA-guided RNAi and Ago2-dependent Dicer-independent miRNA biogenesis.
Discussion
Ago2-mediated miRNA biogenesis and processing are essential for the development in 
eukaryotes. We found that eIF1A directly binds to Ago2 in an RNA-independent manner, 
and plays a role in both Ago2-mediated miRNA-guided RNAi and miRNA biogenesis (Fig. 
6). Using biochemistry and NMR analyses, we demonstrated that MID-domain of Ago2 
binds to the globular domain of eIF1A. eIF1A promotes Ago2-mediated RNAi and miR-451 
biogenesis in vitro and in vivo. eIF1A augments erythrocyte maturation in zebrafish through 
mediating miR-451 surveillance. The previously unrecognized roles of eIF1A in Ago2-
mediated miRNA processes identified here provide insights into the understanding of the 
mechanisms of miRNA-guided RNAi and miRNA biogenesis.
Interestingly, point mutation of K56A in eIF1A leads to dissociation of eIF1A-Ago2 
interaction. The eIF1A (K56A) mutant does not impair translation initiation. In contrast, 
eIF1A(K56A) impairs Ago2-mediated miRNA guided RNAi and Ago2-dependent miR-451 
production in vitro and in zebrafish in vivo. Consistently, miR-451 partly reverts reduced 
hemoglobinization and delayed maturation of erythrocytes in eif1axb knockdown zebrafish 
with overexpressed heIF1A (K56A). These data demonstrate that eIF1A-Ago2 interaction 
promotes Ago2-mediated RNAi and miRNA production but does not compromise eIF1A 
functions in translation initiation.
Recently, groups of Ameres et al.40, Cheloufi et al.14, and Cifuentes et al.15 have reported 
that recombinant Ago2 is sufficient for slicer activity with large quantities of RNA 
fragments in RNAi and miR-451 processing in vitro. These data elegantly evidenced that 
Ago2 is a central effector of miR-451 generation and RNAi processes. On the other hand, 
many studies demonstrated that the Ago2-centered RISC complex is necessary for efficient 
RNAi activity with long and/or structured mRNAs and miR-451 processing in vivo23,41. It is 
possible that other components in RISC are needed to resolve mRNA secondary structure, to 
scan the long and/or structured mRNAs for recognition of miRNA seed regions in low 
abundance, and to generate mature miR-451. Currently, the component list of RISC is 
increasing. Here we show that eIF1A directly binds to Ago2 and augments miR-451 
biogenesis and RNAi processes, suggesting that eIF1A is an important but previously 
unrecognized factor of RISC.
MID-domain of Ago2 is essential for miRNA docking in RISC mediated RNAi and pre-
miR-451 loading in Dicer-independent miR-451 biogenesis. Here, we found that eIF1A 
directly binds to MID-domain of Ago2 and eIF1A promotes miRNA-guided RNAi and 
miR-451 generation.
Our findings reveal that eIF1A directly interacts with Ago2 and augments Ago2-mediated 
miRNA-guided RNAi and DICER-independent miRNA biogenesis. The newly identified 
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eIF1A–Ago2 complex together with its functions in miRNA processes provides insights in 
understanding how Ago2 mediates miRNA processes in translation, development and 
diseases.
Methods
Plasmids, antibodies and reagents
Constructs of human Flag-HA-Ago1(10820), Ago2 (10822) Ago3 (10823) and Ago4 
(10824) were obtained from Addgene. The cDNAs of human eIF1A were PCR-amplified 
from HEK293 cDNAs. Human eIF1A was inserted into NotI/EcoRI sites of the pIRESneo 
vector. Mutants of eIF1A: N-tail deletion (ND, 25~144aa, amino acid), C-tail deletion (CD, 
1~114aa), globular domain (GD, 25~114aa) were generated by PCR and inserted into NotI/
EcoRI sites of the pIRESneo vector encoding an N-terminal with Flag-HA. Monoclonal 
anti-Flag (#8146S) antibody (20μl for immunoprecipitation assay), monoclonal anti-HA 
antibody (6E2, 2367S, 20μl for immunoprecipitation assay) and monoclonal anti-GFP 
antibody (#2956S, 20μl for immunoprecipitation assay, 1:1000 dilution for Western blot 
assay), and anti-β-Tubulin (2146S, 1:1000 dilution for Western blot assay) were ordered 
from Cell Signaling. Monoclonal anti-eIF1A antibody (Ab172623, 20μl for 
immunoprecipitation assay; 1:1000dilution for western blot assay), monoclonal anti-human 
Ago2 antibody (ab57113, used to detect human and zebrafish Ago2, 1:1000 dilution in 
western blot assay, 20μl for immunoprecipitation assay), and polyclonal anti-actin (ab1801, 
for zebrafish actin detection with 1:1000 dilution in Western blot assay) were bought from 
Abcam. Polyclonal anti-Ago1 (SAB4200065, 1:1000 dilution in Western blot assay) and 
Ago3 (SAB4200112, 1:1000 dilution in Western blot assay) antibodies were purchased from 
Sigma. Polyclonal anti-Ago4 antibody (MABE139, 1:1000 dilution in Western blot assay) 
was ordered from Millipore. Ribonuclease A was ordered from Sigma. Benzonase nuclease 
was ordered from VWR. HEK293 (CRL-1573™), HeLa (CCL-2™) and T98G (CRL-1690™) 
cells were ordered from ATCC. SilverXpress® Silver Staining Kit was purchased from 
Invitrogen. CellTiter-Glo® Luminescent Cell Viability Assay Kit was bought from 
Promega.
Immunoprecipitation, MS and Western blot assays
The stable HEK293 cell line expressing Flag-HA (as a control) or Flag-HA-Ago2 were 
lysed with lysis buffer containing 20mM Tris HCl pH7.4, 137mM NaCl, 10% glycerol, 1% 
NP-40, EDTA- free protease inhibitor (Roche) followed by 10μg/ml Ribonuclease A 
treatment (25°C, 1hr). The Ago2 interacted proteins were immunoprecipitated by anti-HA 
monoclonal antibodies (Cell Signaling, 2367S, 20μl for immunoprecipitation assay) 
immobilized to Dyna beads. The purified proteins were analyzed by silver staining and Mass 
Spectrometry via LC-MS/MS on an LTQ Orbitrap Velos mass spectrometer (Thermo 
Scientific, German) equipped with a Thermo Fisher Scientific nanospray source, an Agilent 
1100 Series binary HPLC pump, and a Famos autosampler. The spectral data were searched 
with SEQUEST against a database containing the human International Protein Index (IPI) 
protein sequence database: (http://www.ebi.ac.uk/IPI/) together with the reversed 
complement. eIF1A was transiently overexpressed in stable HEK293 cell lines expressing 
Agos (Ago1~ 4). The cell lysates were treated with 10μg/ml Ribonuclease A (25°C, 1hr). 
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Immunoprecipitated proteins by anti-eIF1A monoclonal antibodies (Abcam, Ab172623, 
20μl for immunoprecipitation assay) were analyzed by western blotting with anti-Agos (1~ 
4) antibodies (monoclonal anti-Ago2 antibodies, Abcam, ab57113, 1:1000 dilution; 
polyclonal anti-Ago1/3, Sigma, SAB4200065, SAB4200112, 1:1000 dilution); Ago4 
Millipore, MABE139, 1:1000 dilution)antibodies in immunoblotting (IB).
Expression and purification of eIF1A and Ago2 fragments
The cDNA for MID-domain of human Ago2 (His-Sumo-tagged) was provided by Bhushan 
Nagar (McGill University). Human eIF1A and mutants of eIF1A-ND/-CD/-GD were 
inserted into EcoRI/NotI sites of pGEX-4E-1 vectors with GST fusion at the N-term. Human 
Ago2 (full length) and fragments of L1(172 ~ 227aa), PAZ(227 ~ 349aa), MID (432 ~ 
575aa) and PIWI (590 ~ 816aa) were inserted into NdeI/BamHI sites of a pET-6H2 vector. 
His-tagged proteins expressed in BL21(DE3) cells were extracted by sonication with lysis 
buffer (50mM Tris, 350mM NaCl, 10mM Imidazole, pH8.0, 20μM Benzonase nuclease, 
10μg/ml RNase A, 100μg/ml lysozyme, 2% NP-40, 0.05% β-mercaptoethanol and protease 
inhibitor) followed by Ni-agarose resin (Qiagen) purification. GST-tagged proteins 
expressed in BL21(DE3) cells were extracted by MagneGST™ Protein Purification System 
(Promega) or Pierce Glutathione Magnetic Beads (Thermo Scientific).
GST-pull down assays
E. coli expressed GST-tagged human eIF1AX (known as eIF1A), or globular domain (GD, 
25 ~114aa), or N-tail deletion (ND, 25~144aa) or C-tail deletion (CD, 1~114aa) were 
purified by GST-pull down assays (#88822, Thermo Scientific) with glutathione magnetic 
beads from pre-cleared cell lysates of HEK293 cells stably expressing HA-Ago2 in the 
presence of 10μg/ml Ribonuclease A treatment. Western blot assays were performed with 
anti-Ago2 monoclonal antibodies (Abcam, ab57113, 1:1000 dilution). For the Ago2 domain 
screening assays, E. coli expressed His-tagged L1, PAZ, sumo-MID, PIWI domains and 
Sumo, which were purified by Ni-NTA resin, were performed GST-pull down assays with 
E. coli expressed GST-eIF1A. Western blot assays were performed with anti-His 
monoclonal antibodies (Cell Signaling, #2366S, - 1:1000 dilution).
Nuclear Magnetic Resonance (NMR) titrations
BL21(DE3) bacterial cells harboring His-SMT3, His-SMT3-tagged MID(432 ~ 575aa) and 
His-tagged eIF1A grown in either LB or minimal media containing 15N Ammonium 
Chloride. The resulting cell pellets were lysed by sonication or french press with lysis buffer 
(50mM Tris, 350mM NaCl, 10mM Imidazole, pH8.0, 20μM Benzonase nuclease, 10μg/ml 
RNase A, 100μg/ml lysozyme, 2% NP-40, 0.05% β-mercaptoethanol, protease inhibitor). 
The soluble proteins were loaded onto a Ni-agarose resin (Qiagen) and proteins were eluted 
with Ni-elution buffer (50mM Tris, 350mM NaCl, 350mM Imidazole, pH8.0). Purified 
proteins in Ni-elution buffer were further purified by size exclusion chromatography using a 
S75 column and eluting with HEPES buffer (20mM HEPES, 150mM NaCl, 0.5mM TCEP, 
pH7.2). The HSQC measurements were carried out on a Bruker 500 MHz and Varian 600 
MHz instrument each equipped with a cryogenically cooled probe. The data was processed 
using NMRPipe and visualized using CARA. The molar ratios of 15N-eIF1A: SMT3-MID at 
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1:1 were analyzed in this study and the concentration of 15N-eIF1A was at 200μM. 
Similarly 15N-SMT3-MID was held at concentration of 200μM and unlabeled eIF1A was 
titrated at molar ratio of 1:1.
Ago2-mediated RNAi and miR-451 biogenesis in vitro assays
Target miRNA cleavage analyses14,15 for Ago2 proteins were performed. Briefly, 
overexpressed HA-Ago2, HA-eIF1A, HA-eIF1A mutants (V55A, K56A, K67A) proteins 
were purified with anti-HA antibodies and Dyna beads (Invitrogen) from HEK293 cells via 
native methods. For the in vitro miRNA mediated RNA slicing assays, 100μM let-7a 
(Dharmacon) and linearized 5μM 5′-32P end-labeled synthetic HMGA2 3′-UTR mutant 
(IDT) were performed Ago2 cleavage analyses were incubated with eIF1A in a series of 
concentrations (0.01μg/μl, 0.1 μg/μl, 0.3 μg/μl) or eIF1A mutants (0.3 μg/μl) at 37°C for 4h 
in a 10μl reaction volume. The reaction contained 3μg of yeast tRNAs, 25mM HEPES-
KOH, pH7.5, 50mM potassium acetate, 5mM magnesium acetate, 5mM DTT, 0.1μl (1μg/μl) 
native HEK293 cell lysates, 100μM let-7a and linearized 5μM 5′-32P end-labeled synthetic 
HMGA2 3′-UTR mutant, with/without 0.2 μg/μl Ago2. For the in vitro pre-miR-451 
cleavage analysis, 5μM of 5′-32P end-labeled synthetic pre-miR-451 (Dharmacon) and 0.2 
μg/μl Ago2 were incubated with eIF1A in a series of concentrations (0.01μg/μl, 0.1 μg/μl, 
0.3 μg/μl), or eIF1A mutants (V55A, K56A, K67A) (0.3 μg/μl) in a 10 μl reaction volume at 
37°C for 4h. The reaction contained 3μg of yeast tRNAs, 25mM HEPES-KOH, pH7.5, 
50mM potassium acetate, 5mMmagnesium acetate, 5mM DTT, and 0.1μl (1μg/μl) native 
HEK293 cell lysate. The ethanol precipitated RNAs were analyzed in 4~20% Mini-
PROTEAN® TBE Precast Gel (BioRad). The gel was quantified by Phosphorimager 
analyses.
Endogenous miRNA-guided RISC activity assays
To read miRNA-guided RISC activity, pcDNA-GFP-let 7 (complementary sequence of 
miRNA let-7, 5′-AACTATACA ACCTACTACCTCA-3′) were generated in HEK293 cells 
as previously described36. The pcDNA-GFP-let 7 was transfected into HEK293 cells 
followed by 1.6mg/ml G418 selection for two weeks. The resistant colonies were 
propagated into stable cell lines. For let-7 RISC activity assay, 2μg of expression constructs 
were transfected into 5×105 cells of the GFP–reporter stable cell lines in six-well plates, the 
cells were transferred to 10cm plates after 24h. After 36hr, total proteins were extracted with 
standard RIPA buffer together with protease inhibitor (Roche) and total RNAs were 
extracted using Trizol reagents (Invitrogen). Control Morpholino (MO) or 62.5μM eif1axb 
MO plus 1μg/μl human eIF1A or mutant mRNAs were injected into one-cell stage zebrafish 
embryos. Total RNAs and proteins were isolated at 48 h.p.f. for the analyses of c-Myb 
proteins and mRNAs.
Zebrafish eif1axb knockdown and mRNA microinjection
The wild type AB/C32-strain zebrafish were used in this study. All the experiments were 
conducted according to US National Institutes of Health guidelines for animal research and 
were approved by Harvard Medical Animal Committee. The morpholino targeting +1~+25 
of eif1axb (5′-CTCCTTTTCCTTTGTTTTTCGGCAT-3′) and control morpholino (5′-
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CCTCTTACCTCA GTTACAATTTATA-3′) were obtained from Gene-Tools. Zebrafish 
embryos were injected at the one-cell stage with 1nl of 250μM control, 250μM eif1axa, 
250μM eif1axb, 125μM eif1axb and combined 125μM eif1axa+125μM eif1axb morpholino 
with a PLI-100A Pico-Injector. Images were taken at 19 h.p.f, 28 h.p.f. and 45h.p.f.
Total RNAs and proteins were extracted for microRNA, quantitative real-time PCR (qPCR) 
and Western blot assays. Antibodies of anti-Ago2 (ab57113, monoclonal), anti-eIF1A 
(ab38976, polyclonal), and anti-c-Myb (ab62824, polyclonal) ordered from Abcam were 
used in zebrafish western blot assays. Antibodies of anti-β-actin (#4967, polyclonal) were 
ordered from Cell Signaling. The qPCR assays were performed with primers (forward and 
backward): 5′-GAACGGCATCAAGGTGAACTT-3′ and 5′-
GACGACCTCGAGTGAGGTAGTAGGTTG TATA-3′ for GFP-let-7; 5′-
AAATCTGGCACCACACCTTCTAC-3′ and 5′-GATAGCACA GCCTGGATAGCAAC-3′ 
for human β-actin; 5′-GCATCATGGTTCTGAAGACTGG-3′ and 5′-
CTTCTGCACCAACTCAATCACC-3′ for c-Myb; 5′-GACCCAGACATCAGGGAGT 
GAT-3′ and 5′-ATGCCAGATCTTCTCCATGTCA-3′ for zActin; 5′-CCAGGATGTCAAA 
GCAGATGTC-3′ and 5′-ATGTCGTCATCGTTCTCTCCAA-3′ for eif1axa; 5′-
TCATCAAG ATGTTGGGAAATGG-3′ and 5′-CCTAGCCTCGTCGGCATTATAC-3′ for 
eif1axb.
Northern blot assays
Total RNAs were isolated from HEK293 cells, stable HEK293 cells expressing 
eIF1Amutants (V55A, K56A, or K67A), and developing zebrafish with Trizol (Invitrogen). 
25μg total RNAs were loaded into each well of TBE precast gel (Bio-Rad). Northern blot 
experiments were performed with semi-dry transfer cell and 5′-32P labeled probes. The 
mature miR-451 and miR-144 specific probes sequences are: 5′-
AACUCAGUAAUGGUAACGGUUU-3′ for miR-451; 5′-AGUACAUCAUCUAUACU 
GUA-3′ for miR-144. U6 probe: 5′-AAAAAUAUGGAACGC UUCACGAAUUUG-3′ for 
U6 (probes were ordered from IDT).
Taqman real-time PCR
Mature miRNA specific Taqman real-time PCR were performed as TaqMan® manufacture 
(Taqman microRNA reverse transcription Kit, TaqMan® Universal Master Mix II, no UNG 
Mini-Pack, and TaqMan® Small RNA Assay) described with the following sequences: 
let-7(5′-UGAGGUAGUAGGUUGUAUAGUU-3′), miR-126(5′-UCGUAC 
CGUGAGUAAUAAUGC-3′). Data were normalized to let-7 in zebrafish samples and 
calculated as manufacture described. The standard deviations were obtained from three 
independent experiments.
mRNA preparation and rescue analyses
The pCS2Flag constructs (pCS2Flag-vector from Addgene, 16331#) harboring genes 
encoding human eIF1A or eIF1A (K56A) were linearlized with ApaI restriction enzyme. 
The mRNAs were prepared with mMESSAGE mMACHINE® SP6 Kit (Invitrogen) 
following the manufacturer’s instructions. The mRNAs were purified with RNeasy Plus 
Mini Kit (Qiagen) with RNase-free H2O. Rescue of the eif1axb MO (62.5μM, 1nl) 
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introduced zebrafish was performed by injection of 1000pl of a 1μg/μl mRNA encoding 
human eIF1A or eIF1A (K56A) into wild type one-cell-stage zebrafish embryos. 
Experiments with injection of 1000pl of eif1axb MO (62.5μM) plus 1μg/μl mRNA encoding 
human eIF1A (K56A) and 0.2 μg/μl miR-451(IDT) were performed.
Site-directed mutagenesis
The pfu-PCR assays for the site-directed mutagenesis of V55A, K56A and K67A of HA-
tagged human eIF1A were performed with the following primers: V55A: Sense: 5′-
GCAATGTGTTTCGATGGTGCAAAGAGGTTATGTC ACATC-3′; Antisense: 5′-
GATGTGACATAACCTCTTTGCACCATCGAAACACATT GC-3′; K56A: Sense: 5′-
GAAGCAATGTGTTTCGATGGTGTAGCGAGGTTATGTCA CATCAG-3′; Antisense: 
5′-CTGATGTGACATAACCTCGCTACACCATCGAAACACATTGCTTC-3′; K67A: 
Sense: 5′-GTCACATCAGAGGAAAATTGAGAGCAAAGGTTTGGATAAATA 
CCTCGG-3′; Antisense: 5′-CCGAGGTATTTATCCAAACCTTTG 
CTCTCAATTTTCCTCTG ATGTGAC-3′. The reactions in volume of 10μl of each with 
sense primers or antisense primers were separately performed pfu-PCR with procedures: 1) 
95°C, 3 minutes; 2) 95°C, 20 seconds; 3) 65°C 20seconds; 4) 72°C, 5–12 minutes; 10 cycles 
(step 2 ~ 4); 5) 72°C, 10 minutes; 6) 4 °C. Combine the sense reaction and antisense reaction 
products (total volume of 20 μl for each reaction) and continue pfu-PCR with procedures: 1) 
95°C, 3 minutes; 2) 95°C, 20 seconds; 3) 65°C 20seconds; 4) 72°C, 5–12 minutes; 20 cycles 
(step 2 ~ 4); 5) 72°C, 10 minutes; 6) 4 °C. The pfu-PCR products were digested with DpnI 
restriction enzyme (New England Biolabs) at 37°C for 2hr. The DNAs were transformed 
into Z-Competent™ E. Coli Cells-Strain Zymo 5α (Zymo Research). Constructs, which were 
validated by sequencing, harboring correct sequences encoding HA-tagged eIF1A (V55A), 
eIF1A (K56A) and eIF1A (K67A) were used in this study.
Polysome Profiling
Growth medium was aspirated and cells were washed with PBS, recovered in lysis buffer 
(50 mM HEPES/KOH pH 7.5, 100 mM NH4Cl, 25 mM MgCl2, 1 mM DTT, 0.5% (w/v) 
Triton X-100) and passed 6x through a 27-gauge needle. Insoluble material was removed by 
a 3-minute spin (microcentrifuge, 20817 rcf). All steps during sample preparation were done 
on ice or at 4°C. ≈ 100 μl of the lysates (corresponding to ≈ 2×106 cells) were loaded onto 
linear sucrose density gradients (10–40% (w/v) sucrose in lysis buffer) and centrifuged for 
2h at 40000 rpm (SW40 rotor, Beckman Coulter) at 4 °C. The gradients were fractionated on 
a Piston Gradient Fractionator (BioComp Instruments, Fredericton, Canada) and ribosome 
profiles were recorded at 260 nm.
In Vitro Translation Assays
The dicistronic reporter construct, containing the Renilla luciferase sequence after the 5′ 
UTR followed by the CrPV IRES and the firefly luciferase sequence, has been previously 
described42. The reporter construct plasmid was linearized with BamHI (New England 
Biolabs) and transcribed in vitro with an ARCA cap and poly (A)-tailed using the mMessage 
Machine T7 Ultra Kit (Ambion). The mRNAs were purified with RNeasy Plus Mini Kit 
(Qiagen) with RNase-free H2O. Human eIF1A and mutants (V55A, K56A and K67A, with 
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anti-Flag antibodies, 0.15mg/ml, 2μl per reaction per reaction) were purified with Dyna 
beads (Invitrogen) from HEK293 cells with transient transfection of plasmids encoding 
Flag-tagged eIF1A and eIF1A mutants. In vitro translation reactions (50μl per reaction) were 
carried out using Rabbit Reticulocyte Lysate (Promega, 35μl per reaction) with 2mM 
magnesium acetate and 60mM potassium acetate, which was incubated at 30°C for 100 min. 
Translation of the reporter genes was measured using the Dual-Glo luciferase assay 
(Promega). Three independent experiments were performed.
O-Dianisidine staining
O-dianisidine (Sigma) solution at 0.7 mg/ml was prepared in fresh ethanol and protected 
from exposure to light. The staining solution was prepared by mixing 2 ml of water, 2 ml of 
0.7 mg/ml O-dianisidine solution, 0.5 ml of 100 mM sodium acetate, and 100 μl 3% 
hydrogen peroxide. PTU treated 48 h.p.f embryos were transferred to 12-well plates and 1 
ml of the staining solution was added. Stained embryos were kept in the dark for 15 minutes, 
washed three times with 1 × PBS, and fixed with 4% paraformaldehyde.
May-Grünwald/Giemsa staining
Erythrocytes collection of 20 zebrafish (56 h.p.f) of each group was performed by cutting 
the zebrafish tails. Circulating erythrocytes were collected with 1 × PBS with 10% FBS with 
cytospin. The erythrocytes on slides were stained with May-Grünwald/Giemsa solutions 
(Polysciences), imaged and photographed using a Nikon 80i Upright Microscope. The pixel 
area of the nucleus and cytoplasm was quantified for 100–145 cells per sample in three 
independent experiments using ImageJ software and the nuclear: cytoplasmic ratio 
calculated for each cell.
Image acquisition
In O-Dianisidine staining assays, stained embryos were imaged and photographed using a 
Leica M80 Microscope with a Nikon D200 digital camera using an adjustable flash system. 
Erythrocytes with May-Grünwald/Giemsa staining were imaged by Nikon 80i Upright 
Microscope in Nikon Image Center at Harvard Medical School. Fluorescence and/or DAPI 
stained images were taken with a Nikon Ti Inverted Fluorescence Microscope with Perfect 
Focus System in Nikon Image Center at Harvard Medical School. Images of zebrafish 
embryos were taken by a Leica M80 Microscope with a Nikon D200 digital camera.
Statistical analyses
All statistical experimental data are presented as mean ± s.d. (n = 3 or more). P-value was 
determined by Student’s t-test (tail = 2). *** p < 0.01.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. eIF1A interacts with Ago2
(a) Proteins co-immunoprecipitated with Flag-HA-Ago2 from HEK293 cells were separated 
by SDS-PAGE (silver staining) and analyzed by mass spectrometry. eIF1A is a novel Ago2 
interacting protein (*:detected peptides of eIF1A). (b) Fluorescence immunostaining was 
performed with anti-eIF1A (monoclonal) and anti-Ago2 (monoclonal) antibodies and DAPI 
(4′,6-diamidino-2-phenylindole) in HEK293 and human glioblastoma multiforme T98G 
cells. White arrows show the co-localized eIF1A and Ago2. (c) eIF1A interacts with Ago2. 
Human eIF1A was transiently overexpressed in stable HEK293 cells stably expressing Agos 
(1~4). Immunoprecipitation assays were performed with anti-eIF1A (monoclonal) antibody 
and immuno blotting (IB) with anti-Agos antibodies in the upper panel and anti-eIF1A 
antibodies in the bottom panel.
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Figure 2. eIF1A binds to MID-domain of Ago2 in a RNA-binding-independent manner
(a) Human eIF1A interacts with the MID fragment of human Ago2. Recombinantly 
expressed and Benzonase-treated Ago2 fragments and recombinantly expressed GST-eIF1A 
were used for GST-pull down analyses followed by Western blotting with anti-His 
antibodies (IB, immuno-blotting). The arrow shows that the MID fragment interacts with 
eIF1A. (b) The globular domain (GD) of eIF1A interacts with Ago2. Recombinantly 
expressed and Benzonase-treated GST, GST-eIF1A and mutants (ND, 25 ~ 144aa; CD, 1 ~ 
114aa; GD, 25 ~ 114aa) were used for GST-pull down assays with cell lysates of HEK293 
stably expressing Ago2. (c) 1H-15N TROSY-HSQC spectrum of 15N-eIF1A titrated with the 
sumo-MID (432 ~ 575aa). The titration of RNA-free-sumo-MID leads to broadening of 
RNA free 15N-eIF1A resonances (molar ratio of 1:1). Inserted frames show the broadening 
of resonances of V55, K56 and K67 residues in eIF1A upon MID titration. (d) 1H-15N 
TROSY-HSQC spectrum of 15N-Sumo-MID titrated with eIF1A. The titration of eIF1A 
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(molar ratio of 1:1) results in broadening 1H-15N TROSY-HSQC crosspeaks coming from 
the 15N-MID domain, but not from 15N-Sumo (SMT3) tag. Inserted frames show the 
broadening of resonances of residues from MID-domain, but not from SMT3-Tag (SUMO-
tag), upon eIF1A titration.
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Figure 3. Lys56 in eIF1A is important for full length eIF1A-Ago2 interaction but K56A mutation 
in eIF1A does not impair translation initiation
(a) Immunoprecipitation (IP) assays were performed with and anti-Flag antibodies in 
HEK293 cell lines stably expressing Flag-tagged eIF1A and eIF1A mutants. Bottom panel: 
immunoprecipitation assays were performed with anti-Ago2 antibodies. Immunoblotting 
(IB) assays were performed with anti-eIF1A and anti-Ago2 antibodies. (b) 0.3μg added 
purified Flag-eIF1A (K56A) mutants per reaction display the similar promotion effects as 
0.3μg added purified Flag-eIF1A and Flag-eIF1A mutants per reaction in cap-dependent and 
IRES-dependent translation in dual luciferase assays in vitro. Relative luminescence results 
were shown. Three independent experiments were performed (mean ± s.d., n = 3). (c) 
Polysome profiling analyses with HEK293 cell lines stably expressing eIF1A or eIF1A 
(K56A). Extracts of the indicated cell lines were subjected to sucrose density gradient 
centrifugation. The ribosome profiles (recorded at 260 nm) and the positions of the 40S/60S 
ribosomal subunits, 80S monosome and polyribosomes are shown.
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Figure 4. eIF1A augments Ago2-mediated RNAi
(a) Sequence of the human HMGA2 3′-UTR fragment mutant with two native let-7 target 
sites. Filled circles: Watson-Crick complementarity; open circles: non-Watson-Crick 
complementarity. Mutated nucleotides are shown in blue and wild type nucleotides were 
underlined (to neutralize site 2 and to reduce self-complementarity). (b) In vitro effects of 
eIF1A on Ago2-mediated RNA cleavage. eIF1A or the indicated mutants were incubated 
with Ago2, synthetic let-7a and 5′-32P end-labeled HMGA2 3′-UTR mutants. RNAs were 
analyzed by Northern blot and autoradiographs analyses. (c) Statistical analyses of three 
independent in vitro assays in (b). (d) Western blot assays of effects of eIF1A and eIF1A 
(K56A) mutant on GFP-let-7 reporter expression. Ago2, eIF1A or eIF1A (K56A) were 
transiently overexpressed in HEK293 cells stably expressing reporter GFP-let-7. (e)The 
expression ratio between Tubulin and GFP reporter in the same gel were calculated. Intact 
(100%) RISC activity was considered in control cells. The relative RISC activities under 
overexpression conditions of the indicated genes or mutants were obtained by comparison 
with the control. (f) Relative GFP reporter mRNAs in (d) by quantitative real-time PCR 
(qPCR). (g) Western blot assays of zebrafish c-Myb in the indicated zebrafish groups at 28 
h.p.f (control, eif1axb MO (62.5μM, 1nl), eif1axb MO (62.5μM, 1nl) plus human eIF1A 
(heIF1A) (mRNA, 1μg/μl, 1000pl), and eif1axb MO (62.5μM, 1nl) plus heIF1A (K56A) 
mutant (mRNA, 1μg/μl, 1000pl)). Proteins were extracted from >10 zebrafish per group. (h) 
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Relative c-Myb mRNAs in each group in (g) by qPCR. Total RNAs were extracted from >10 
zebrafish per group. (i) Taqman PCR assays of relative zebrafish miR-126 (dre-miR-126) in 
each group in (g). Total RNAs were extracted from >10 zebrafish per group. In all statistical 
comparisons, three independent experiments were performed (mean ± s.d., n = 3 
experiments, Student’s t-test). *** reports p < 0.01.
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Figure 5. eIF1A augments miR-451 biogenesis
(a) In vitro activity of eIF1A in Ago2-mediated cleavage of 5′-32P end-labeled synthetic pre-
miR-451. RNAs were analyzed by Northern blotting and autoradiographs analyses. (b) 
Statistical analyses of the data in (a). Data of three independent experiments were shown 
(mean ± s.d., n = 3, Student’s t-test). (c) Northern blot assays show the effects of eIF1A 
mutants on miR-451 biogenesis in HEK293 cells. Total RNAs were extracted from stable 
HEK293 cells expressing Flag-eIF1A and Flag-eIF1A mutants. Signals show mature 
miR-451 and miR-144 levels with U6 as a loading control. (d) Northern blot assays show 
the effects of eIF1A(K56A) mutant on miR-451 generation in the developing zebrafish. 
Total RNAs were extracted from zebrafish with/without treatments of control MO, eif1axb 
MO (62.5μM, 1nl), eif1axb MO (62.5μM, 1nl) plus heIF1A (mRNA, 1μg/μl, 1nl), eif1axb 
MO (62.5μM, 1nl) plus heIF1A (K56A) (mRNA, 1μg/μl, 1nl). (e) Hemoglobin (brown) was 
visualized by the oxidation of o-dianisidine (o-das) in zebrafish at 48 h.p.f. Hemoglobinized 
cells accumulate in wild type (Group I) and are reduced in eif1axb MO injected embryos 
(Group II). Human eIF1A, but not K56A mutant (Group III, with less hemoglobinized cells), 
rescues hemoglobinized cells in eif1axb MO-injected zebrafish, while miR-451 spares K56A 
caused rescue defects. Scale bar = 100μm. (f) Percentage of embryos with hemoglobinized 
cells in zebrafish. Control group (n=40). eif1axb MO injection (n = 42). Human eIF1A (n = 
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35), but not K56A mutant (n = 35), increased the percentage of embryos with normal 
hemoglobinized cells, while miR-451 (n = 31) suppresses the decreased percentage by 
K56A mutant (p < 0.001). (g) Erythrocytes stained with May-Grünwald/Giemsa are 
representative of the mean of each group at 56 h.p.f. Scale bar = 5μm. (h) Scatterplot of the 
nuclear cytoplasmic ratio (N:C) for each group as readout of erythrocyte maturation 
(Wilcoxonrank-sumtest after Bonferroni correction, p < 10−15). Human eIF1A (n = 120 
erythrocytes), but not K56A mutant (n = 145), rescued erythrocyte maturation impaired by 
eif1axb MO injection, while miR-451(n = 118) spares distribution difference in 
heIF1A(K56A) mutant group. ***p < 0.01.
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Figure 6. Schematic diagram for eIF1A functions in Ago2-dependent miR-451 biogenesis, RNA 
interference and erythrocyte maturation in zebrafish
The primary miRNA (priRNA) is cleaved by Drosha-DGCR8 pathways to generate pre-
miRNA within the nucleus. Exportin-5 in complex with Ran-GTP exports the pre-miRNA to 
the cytoplasm, where the pre-miRNA is bound by DICER to form a RISC Loading Complex 
that includes Ago2. In the canonical miRNA biogenesis pathway, DICER removes the 
terminal loop region to yield the mature miRNA. The pre-miR-451 is loaded directly onto 
Ago2 and sliced on the 3′ hairpin arm. The miR-144 biogenesis is DICER-dependent. The 
globular domain (GD) of eIF1A directly binds to MID-domain of Ago2 and forms an 
eIF1A-Ago2 complex promoting Ago2-mediated RNAi and miR-451 biogenesis. MID-
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domain of Ago2 binds to the GD of eIF1A and does not impair eIF1A functions in 
translation initiation. The 5′-term of guide strand of miRNA-miRNA* duplex is docked onto 
a pocket with residues mainly from MID-domain. The long and structured mRNAs are 
scanned by RISCs to recognize seed regions in miRNAs. After perfect or imperfect 
complementary guide with miRNAs, mRNAs are nicked by PIWI domain resulting in 
RNAi. eIF1A augments Ago2-mediated RNAi, miR-451 production and erythrocyte 
maturation. Black arrows are from previous reports of other groups14,15,43; blue arrows are 
from this study.
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